Elequin Capital LP Lantheus Holdings, Inc. Transaction History
Elequin Capital LP
- $825 Million
- Q4 2024
A detailed history of Elequin Capital LP transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Elequin Capital LP holds 145 shares of LNTH stock, worth $14,569. This represents 0.0% of its overall portfolio holdings.
Number of Shares
145Holding current value
$14,569% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding LNTH
# of Institutions
533Shares Held
73.2MCall Options Held
598KPut Options Held
371K-
Black Rock Inc. New York, NY8.6MShares$864 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.24MShares$728 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X06.2MShares$623 Million0.29% of portfolio
-
Farallon Capital Management LLC San Francisco, CA5.32MShares$534 Million2.53% of portfolio
-
State Street Corp Boston, MA2.64MShares$265 Million0.01% of portfolio
About Lantheus Holdings, Inc.
- Ticker LNTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 68,741,904
- Market Cap $6.91B
- Description
- Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...